Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients
Paolo Muratori, Alessandro Granito, Georgios Pappas, Luigi Muratori – 28 April 2009
Golgi protein 73 as a biomarker of hepatocellular cancer: Development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies
Claus J. Fimmel, Lorinda Wright – 28 April 2009
The structure behind diversity: Covariance networks in hepatitis C virus sequences are associated with treatment response
Jacob Nattermann, Frank Tacke – 28 April 2009
Closing the gap: The tight junction protein occludin and hepatitis C virus entry
Nicholas S. Eyre, Thomas F. Baumert, Michael R. Beard – 28 April 2009
Adipocyte‐hepatocyte crosstalk and the pathogenesis of nonalcoholic fatty liver disease
Briohny Smith, Jacob George – 28 April 2009
Ascites and variceal bleeding occurring in a 20‐year‐old with cystic fibrosis
M. Isabel Fiel, Thomas Schiano – 27 April 2009
Small size and disease severity in living donation: A difficult match
Kim M. Olthoff – 27 April 2009
The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis
Pei‐Chun Tsai, Tz‐Win Fu, Yi‐Ming Arthur Chen, Tsui‐Ling Ko, Tien‐Hua Chen, Yang‐Hsin Shih, Shih‐Chieh Hung, Yu‐Show Fu – 27 April 2009 – We investigated the effect of human umbilical mesenchymal stem cells (HUMSCs) from Wharton's jelly on carbon tetrachloride (CCl4)–induced liver fibrosis in rats. Rats were treated with CCl4 for 4 weeks, and this was followed by a direct injection of HUMSCs into their livers.
Hepatitis B: The virus and disease
T. Jake Liang – 27 April 2009 – Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common cause of liver disease and liver cancer. HBV, a member of the Hepadnaviridae family, is a small DNA virus with unusual features similar to retroviruses. HBV replicates through an RNA intermediate and can integrate into the host genome. The unique features of the HBV replication cycle confer a distinct ability of the virus to persist in infected cells.
Vascular disorders of the liver
Laurie D. DeLeve, Dominique‐Charles Valla, Guadalupe Garcia‐Tsao – 27 April 2009